季度业绩表现 - 季度每股亏损为1.35美元，远高于市场预期的每股亏损0.51美元，也高于去年同期每股亏损0.6美元 [1] - 本季度盈利意外为-164.71%，而上一季度盈利意外为+54.12%，当时实际每股亏损0.39美元，优于预期的每股亏损0.85美元 [1] - 在过去四个季度中，公司仅有一次超过每股收益预期 [2] - 季度收入为1124万美元，大幅超过市场预期82.80%，去年同期收入为零 [2] 股价表现与市场展望 - 今年以来公司股价已上涨约91.5%，同期标普500指数涨幅为16.5% [3] - 公司当前Zacks评级为第2级（买入），预计短期内股价表现将优于市场 [6] - 业绩公布前，盈利预期修正趋势向好 [6] 未来业绩预期 - 对下一季度的市场普遍预期为每股亏损0.42美元，收入2207万美元 [7] - 对本财年的市场普遍预期为每股亏损2.44美元，收入1875万美元 [7] 行业比较与同业公司 - 公司所属的医疗-生物医学和遗传学行业，在Zacks行业排名中位列前39% [8] - 同业公司Arvinas Inc (ARVN) 预计在即将公布的报告中季度每股亏损为0.75美元，同比变化-10.3% [9] - 过去30天内，Arvinas的季度每股收益预期已上调7.1%至当前水平 [9] - Arvinas预计季度收入为2698万美元，较去年同期下降73.7% [10]

Harmony Biosciences Holdings, Inc. (HRMY) came out with quarterly earnings of $0.87 per share, missing the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.79 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -5.43%. A quarter ago, it was expected that this company would post earnings of $0.78 per share when it actually produced earnings of $0.68, delivering a surprise of -12.82%.Over the last four qu ...

Amicus Therapeutics (FOLD) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.1 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +41.67%. A quarter ago, it was expected that this pharmaceutical company would post earnings of $0.02 per share when it actually produced earnings of $0.01, delivering a surprise of -50%.Over the last four quart ...

Xometry (XMTR) came out with quarterly earnings of $0.11 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.02 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this marketplace for on-demand manufacturing would post earnings of $0.05 per share when it actually produced earnings of $0.09, delivering a surprise of +80%.Over the last four quarters, the company has surpassed consensus EPS estimates three times.Xomet ...

Anywhere Real Estate (HOUS) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.18. This compares to earnings of $0.05 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -100.00%. A quarter ago, it was expected that this real estate brokerage operator would post earnings of $0.34 per share when it actually produced earnings of $0.32, delivering a surprise of -5.88%.Over the last four quarter ...

CDW (CDW) came out with quarterly earnings of $2.71 per share, beating the Zacks Consensus Estimate of $2.62 per share. This compares to earnings of $2.63 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +3.44%. A quarter ago, it was expected that this information technology company would post earnings of $2.49 per share when it actually produced earnings of $2.6, delivering a surprise of +4.42%.Over the last four quarters, the ...

Kymera Therapeutics, Inc. (KYMR) came out with a quarterly loss of $0.9 per share versus the Zacks Consensus Estimate of a loss of $0.71. This compares to a loss of $0.82 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -26.76%. A quarter ago, it was expected that this company would post a loss of $0.83 per share when it actually produced a loss of $0.95, delivering a surprise of -14.46%.Over the last four quarters, the company ...

Zoetis (ZTS) came out with quarterly earnings of $1.7 per share, beating the Zacks Consensus Estimate of $1.62 per share. This compares to earnings of $1.58 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +4.94%. A quarter ago, it was expected that this animal health company would post earnings of $1.62 per share when it actually produced earnings of $1.76, delivering a surprise of +8.64%.Over the last four quarters, the compa ...

核心业绩表现 - 季度每股收益为2.47美元，超出市场预期的2.41美元，同比增长9.3% [1] - 季度营收为64.9亿美元，超出市场预期0.55%，同比增长3.7% [2] - 过去四个季度中，公司四次超出每股收益预期，三次超出营收预期 [2] 近期股价与市场表现 - 公司股价年初至今下跌约5.4%，而同期标普500指数上涨16.5% [3] - 业绩公布前，盈利预期修正趋势对公司不利，导致Zacks评级为第4级（卖出） [6] 未来业绩预期 - 市场对下一季度的共识预期为每股收益2.68美元，营收67.3亿美元 [7] - 对本财年的共识预期为每股收益10.00美元，营收261.9亿美元 [7] 行业比较与同业表现 - 酒店与汽车旅馆行业在Zacks行业排名中处于后27%的位置 [8] - 同业公司精选酒店预计季度每股收益为2.19美元，同比下降1.8%，营收预期为4.1729亿美元，同比下降2.5% [9][10]

PJT Partners (PJT) came out with quarterly earnings of $1.85 per share, beating the Zacks Consensus Estimate of $1.24 per share. This compares to earnings of $0.93 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +49.19%. A quarter ago, it was expected that this investment bank would post earnings of $1.36 per share when it actually produced earnings of $1.54, delivering a surprise of +13.24%.Over the last four quarters, the co ...